MDK and hepatocellular carcinoma: For example, the HCC and its promoter have been shown to drive the expression of exogenous therapeutic genes in tumors without influencing normal tissues but the percentage expression of the AFP, hTERT and midkine promoters in the HCCs was only 35%, 21.7% and 33% respectively, which was not high [50–53].